Summit X’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Other funds holding ATNM
SM
Summit X's ATNM Position: Q2 2020 in Review
Summit X increased its Actinium Pharmaceuticals (ATNM) stake by 30% in Q2 2020, buying an estimated $3.96K and bringing the position to 2,273 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #203.
Summit X first reported a position in ATNM in Q2 2017 and has held it in 12 quarters since. The position peaked at $26K in Q3 2018. 59 funds tracked by Wall St. Rank hold ATNM as of Q2 2020.
- Summit X held 2,273 shares of Actinium Pharmaceuticals worth $24K as of Q2 2020.
- Summit X bought 523 Actinium Pharmaceuticals shares in Q2 2020, an estimated $3.96K.
- Actinium Pharmaceuticals made up 0.01% of Summit X's portfolio in Q2 2020, its #203 holding.
- Summit X first reported a position in Actinium Pharmaceuticals in Q2 2017 and has held it in 12 quarters since.
- Summit X's Actinium Pharmaceuticals position peaked at $26K in Q3 2018.
- 59 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2020.
Based on Summit X's 13F filing for Q2 2020, filed 13 Aug 2020.